Wimmer Associates 1’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$730K Sell
1,486
-75
-5% -$40.7K 0.36% 62
2025
Q4
$905K Sell
1,561
-1
-0.1% -$566 0.42% 57
2025
Q3
$758K Hold
1,562
0.36% 60
2025
Q2
$633K Hold
1,562
0.32% 61
2025
Q1
$670K Sell
1,562
-15
-1% -$8.12K 0.35% 58
2024
Q4
$820K Sell
1,577
-10
-0.6% -$5.5K 0.41% 56
2024
Q3
$982K Hold
1,587
0.48% 50
2024
Q2
$878K Sell
1,587
-25
-2% -$14.3K 0.45% 53
2024
Q1
$937K Hold
1,612
0.49% 50
2023
Q4
$856K Hold
1,612
0.48% 49
2023
Q3
$816K Sell
1,612
-10
-0.6% -$5.33K 0.51% 48
2023
Q2
$846K Hold
1,622
0.51% 50
2023
Q1
$849K Sell
1,622
-239
-13% -$135K 0.54% 47
2022
Q4
$1.02M Sell
1,861
-70
-4% -$37.1K 0.68% 43
2022
Q3
$992K Sell
1,931
-65
-3% -$36.4K 0.66% 44
2022
Q2
$1.08M Buy
1,996
+45
+2% +$24.8K 0.71% 42
2022
Q1
$1.15M Sell
1,951
-10
-0.5% -$5.74K 0.64% 45
2021
Q4
$1.31M Hold
1,961
0.7% 43
2021
Q3
$1.12M Sell
1,961
-105
-5% -$57.6K 0.66% 44
2021
Q2
$1.04M Sell
2,066
-735
-26% -$347K 0.61% 46
2021
Q1
$1.28M Buy
2,801
+725
+35% +$346K 0.7% 43
2020
Q4
$967K Sell
2,076
-752
-27% -$353K 0.58% 46
2020
Q3
$1.25M Buy
2,828
+760
+37% +$314K 0.84% 36
2020
Q2
$848K Sell
2,068
-773
-27% -$259K 0.66% 43
2020
Q1
$806K Buy
2,841
+180
+7% +$56.8K 0.75% 41
2019
Q4
$864K Sell
2,661
-125
-4% -$37.9K 0.69% 45
2019
Q3
$811K Sell
2,786
-105
-4% -$30.1K 0.71% 46
2019
Q2
$849K Hold
2,891
0.74% 45
2019
Q1
$791K Hold
2,891
0.7% 47
2018
Q4
$647K Sell
2,891
-30
-1% -$7.04K 0.64% 49
2018
Q3
$713K Sell
2,921
-25
-0.8% -$5.75K 0.59% 54
2018
Q2
$610K Sell
2,946
-60
-2% -$12.7K 0.54% 56
2018
Q1
$621K Buy
3,006
+75
+3% +$15.7K 0.55% 54
2017
Q4
$557K Sell
2,931
-200
-6% -$38.3K 0.5% 60
2017
Q3
$592K Hold
3,131
0.55% 58
2017
Q2
$546K Hold
3,131
0.5% 62
2017
Q1
$481K Buy
3,131
+40
+1% +$6.11K 0.45% 68
2016
Q4
$436K Hold
3,091
0.4% 72
2016
Q3
$492K Sell
3,091
-115
-4% -$17.7K 0.44% 68
2016
Q2
$474K Buy
3,206
+35
+1% +$5.17K 0.42% 66
2016
Q1
$449K Buy
3,171
+140
+5% +$18.8K 0.41% 70
2015
Q4
$430K Buy
+3,031
New +$404K 0.45% 67

Other funds holding TMO

Wimmer Associates 1's TMO Position: Q1 2026 in Review

Wimmer Associates 1 reduced its Thermo Fisher Scientific (TMO) stake by 4.8% in Q1 2026, selling an estimated $40.7K and leaving 1,486 shares worth $730K. The position accounts for 0.36% of the portfolio, ranked #62.

Wimmer Associates 1 first reported a position in TMO in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.31M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Wimmer Associates 1 held 1,486 shares of Thermo Fisher Scientific worth $730K as of Q1 2026.
  • Wimmer Associates 1 sold 75 Thermo Fisher Scientific shares in Q1 2026, an estimated $40.7K.
  • Thermo Fisher Scientific made up 0.36% of Wimmer Associates 1's portfolio in Q1 2026, its #62 holding.
  • Wimmer Associates 1 first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 42 quarters since.
  • Wimmer Associates 1's Thermo Fisher Scientific position peaked at $1.31M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.